YouTube on MSN

DIY Magnetic Makeup Board

Transform your makeup routine with our DIY Magnetic Makeup Board tutorial! In this video, we'll guide you through creating a ...
manilatimes

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

WALTHAM, Mass. and DUBLIN, Ireland, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc, (Nasdaq: MURA) ("Mural”), a clinical-stage immuno-oncology company, today announces for the purposes of the ...
Nasdaq

Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting

WALTHAM, Mass. and DUBLIN, Ireland, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc, (Nasdaq: MURA) (“Mural”), a clinical-stage immuno-oncology company, today announces for the purposes of the ...
Investing

XOMA Royalty to acquire Mural Oncology for up to $2.24 per share

WALTHAM, Mass. - XOMA Royalty Corporation (NASDAQ:XOMA) and Mural Oncology plc (NASDAQ:MURA) announced Wednesday they have entered into a definitive agreement for XOMA to acquire Mural for cash ...
Seeking Alpha

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

WALTHAM, Mass., DUBLIN, Ireland and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (MURA), a clinical-stage immuno-oncology company ...
Yahoo Finance

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“Mural”), and XOMA Royalty Corporation ...
Investing

XOMA Royalty to acquire Mural Oncology for up to $2.24 per share

The Mural board of directors has unanimously approved the transaction and recommends shareholders vote in favor of the acquisition. Company directors, who collectively hold approximately 0.42% of ...
Eagle-Tribune

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned ...

WALTHAM, Mass. and DUBLIN and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“Mural”), and XOMA Royalty Corporation ...